In a monumental victory for everyday Americans, President Donald J. Trump has delivered on his promise to slash prescription drug prices—achieving the largest annual decline in over 60 years. Through his bold Most Favored Nation policy and the revolutionary TrumpRx platform, families across the nation are finally seeing prices flatline and, in many cases, plummet.
Trump's Unprecedented Move
Under the Trump-Vance Administration, 17 of the world’s biggest drug manufacturers have agreed to align U.S. prices with the lowest prices offered to comparable developed nations. As a result, prescription drug prices dropped by a staggering 3.9% since Trump took office, with costs continuing to decline month after month in 2026—a feat no previous administration has achieved.
GLP-1 medications, which previously cost over $1,000 a month, now start at just $149. Fertility drugs, inhalers, insulin, and cholesterol treatments have seen price reductions of 50–90% or more, effectively ending the burden of artificially high drug costs that Americans have unjustly shouldered for decades.
An Effective, People-Centric Policy
The results are speaking for themselves: with $700 million already saved for American patients, and the Department of Veterans Affairs locking in more than $10 billion in pharmaceutical savings during this fiscal year, Trump's policies are proving to be a game-changer. While medical care commodities have also decreased by 2.7%, the overarching Most Favored Nation framework promises hundreds of billions more in long-term savings.
Contrast this incredible success with the past failures of the Biden administration. It's clear: while Biden's regime left American families grasping for affordable healthcare solutions, President Trump is steadfastly putting the interests of Americans first, ensuring that inflated drug prices become a relic of a bygone era.
What This Means for Americans
Folks, this is more than just a win on paper—these savings translate to real, tangible relief for millions of Americans who have been forced to choose between healthcare and other necessities. Trump's policies are an emphatic declaration that the days of American patients subsidizing worldwide low drug prices are over.
With President Trump decisively committed to rectifying past injustices in healthcare pricing, the question remains for Patriot readers: will the mainstream media continue to gloss over this historic achievement, or will they finally acknowledge that President Trump is delivering on his promises to the American people?